Pnc Financial Services Group, Inc. Bicycle Therapeutics PLC Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 12,900 shares of BCYC stock, worth $161,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,900
Previous 12,900
-0.0%
Holding current value
$161,121
Previous $292,000
38.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BCYC
# of Institutions
106Shares Held
40.6MCall Options Held
19.6KPut Options Held
16.9K-
Baker Bros. Advisors LP New York, NY10.9MShares$136 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$56.9 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$43.1 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$32.6 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$27.4 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $371M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...